If you made any changes in Pure, your changes will be visible here soon.

Research Output 1959 2019

Filter
Article
2007
15 Citations (Scopus)

Is it the blood pressure or the blood vessel?

Cohn, J. N., Jan 1 2007, In : Journal of the American Society of Hypertension. 1, 1, p. 5-16 12 p.

Research output: Contribution to journalArticle

Blood Vessels
Blood Pressure
Pressure
Microcirculation
Hypertension
58 Citations (Scopus)

Isosorbide Dinitrate and Hydralazine in a Fixed-Dose Combination Produces Further Regression of Left Ventricular Remodeling in a Well-Treated Black Population With Heart Failure: Results From A-HeFT

Cohn, J. N., Tam, S. W., Anand, I., Taylor, A. L., Sabolinski, M. L. & Worcel, M., Jun 1 2007, In : Journal of Cardiac Failure. 13, 5, p. 331-339 9 p.

Research output: Contribution to journalArticle

Isosorbide Dinitrate
Hydralazine
Ventricular Remodeling
Heart Failure
Placebos
13 Citations (Scopus)

Lack of bioequivalence between different formulations of isosorbide dinitrate and hydralazine and the fixed-dose combination of isosorbide dinitrate/hydralazine: The V-HeFT paradox

Tam, S. W., Sabolinski, M. L., Worcel, M., Packer, M. & Cohn, J. N., Sep 26 2007, In : Clinical Pharmacokinetics. 46, 10, p. 885-895 11 p.

Research output: Contribution to journalArticle

Isosorbide Dinitrate
Hydralazine
Therapeutic Equivalency
Tablets
Area Under Curve
532 Citations (Scopus)

Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure

Latini, R., Masson, S., Anand, I. S., Missov, E., Carlson, M., Vago, T., Angelici, L., Barlera, S., Parrinello, G., Maggioni, A. P., Tognoni, G. & Cohn, J. N., Sep 1 2007, In : Circulation. 116, 11, p. 1242-1249 8 p.

Research output: Contribution to journalArticle

Troponin T
Heart Failure
Valsartan
Confidence Intervals
Proportional Hazards Models
30 Citations (Scopus)

Role of nitric oxide deficiency and its detection as a risk factor in pre-hypertension

Gilani, M., Kaiser, D. R., Bratteli, C. W., Alinder, C., Rajala, S., Bank, A. J. & Cohn, J. N., Jan 1 2007, In : Journal of the American Society of Hypertension. 1, 1, p. 45-55 11 p.

Research output: Contribution to journalArticle

Prehypertension
Nitric Oxide
Brachial Artery
Arteries
NG-Nitroarginine Methyl Ester
54 Citations (Scopus)

Statins and symptomatic chronic systolic heart failure: A post-hoc analysis of 5010 patients enrolled in Val-HeFT

Krum, H., Latini, R., Maggioni, A. P., Anand, I., Masson, S., Carretta, E., Ingrillì, F., Pettinati, G., Glazer, R., Tognoni, G. & Cohn, J., Jun 25 2007, In : International Journal of Cardiology. 119, 1, p. 48-53 6 p.

Research output: Contribution to journalArticle

Valsartan
Systolic Heart Failure
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Heart Failure
Mortality
2006
75 Citations (Scopus)

Aldosterone Synthase Promoter Polymorphism Predicts Outcome in African Americans With Heart Failure. Results From the A-HeFT Trial

McNamara, D. M., Tam, S. W., Sabolinski, M. L., Tobelmann, P., Janosko, K., Taylor, A. L., Cohn, J. N., Feldman, A. M. & Worcel, M., Sep 19 2006, In : Journal of the American College of Cardiology. 48, 6, p. 1277-1282 6 p.

Research output: Contribution to journalArticle

Cytochrome P-450 CYP11B2
African Americans
Heart Failure
Alleles
Disease-Free Survival
54 Citations (Scopus)

Cardiovascular Effects of Aldosterone and Post-Acute Myocardial Infarction Pathophysiology

Cohn, J. N. & Colucci, W., May 22 2006, In : American Journal of Cardiology. 97, 10 SUPPL. 1, p. 4-12 9 p.

Research output: Contribution to journalArticle

Aldosterone
Myocardial Infarction
Baroreflex
Plasminogen Activator Inhibitor 1
Extracellular Fluid
262 Citations (Scopus)

Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: The valsartan heart failure (Val-HeFT) data

Masson, S., Latini, R., Anand, I. S., Vago, T., Angelici, L., Barlera, S., Missov, E. D., Clerico, A., Tognoni, G. & Cohn, J. N., Aug 1 2006, In : Clinical chemistry. 52, 8, p. 1528-1538 11 p.

Research output: Contribution to journalArticle

Valsartan
Natriuretic Peptides
Brain Natriuretic Peptide
Heart Failure
Population
459 Citations (Scopus)

From Vulnerable Plaque to Vulnerable Patient-Part III: Executive Summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force Report

Naghavi, M., Falk, E., Hecht, H. S., Jamieson, M. J., Kaul, S., Berman, D., Fayad, Z., Budoff, M. J., Rumberger, J., Naqvi, T. Z., Shaw, L. J., Faergeman, O., Cohn, J. N., Bahr, R., Koenig, W., Demirovic, J., Arking, D., Herrera, V. L. M., Badimon, J., Goldstein, J. A. & 7 others, Rudy, Y., Airaksinen, J., Schwartz, R. S., Riley, W. A., Mendes, R. A., Douglas, P. & Shah, P. K., Jul 17 2006, In : American Journal of Cardiology. 98, 2 SUPPL. 1, p. 2-15 14 p.

Research output: Contribution to journalArticle

Advisory Committees
Atherosclerosis
Myocardial Infarction
Education
Guidelines
81 Citations (Scopus)

Incremental prognostic value of changes in B-type natriuretic peptide in heart failure

Latini, R., Masson, S., Wong, M., Barlera, S., Carretta, E., Staszewsky, L., Vago, T., Maggioni, A. P., Anand, I. S., Tan, L. B., Tognoni, G. & Cohn, J. N., Jan 1 2006, In : American Journal of Medicine. 119, 1, p. 70.e23-70.e30

Research output: Contribution to journalArticle

Brain Natriuretic Peptide
Heart Failure
Confidence Intervals
Mortality
Treatment Failure
38 Citations (Scopus)

Outcomes by Gender in the African-American Heart Failure Trial

Taylor, A. L., Lindenfeld, J., Ziesche, S., Walsh, M. N., Mitchell, J. E., Adams, K., Tam, S. W., Ofili, E., Sabolinski, M. L., Worcel, M. & Cohn, J. N., Dec 5 2006, In : Journal of the American College of Cardiology. 48, 11, p. 2263-2267 5 p.

Research output: Contribution to journalArticle

Isosorbide Dinitrate
Hydralazine
African Americans
Heart Failure
Hospitalization
2 Citations (Scopus)

Prognosis and mechanism of death in treated heart failure: data from the placebo arm of Val-HeFT.

Cohn, J. N., Carson, P. E., O'Connor, C., Opasich, C., Piña, I. L., Scherillo, M., Sinagra, G., Warner-Stevenson, L., Tristani, F. E. & Volpi, A., Jan 1 2006, In : Congestive heart failure (Greenwich, Conn.). 12, 3, p. 127-131 5 p.

Research output: Contribution to journalArticle

Valsartan
Heart Failure
Placebos
Mortality
Sudden Death
77 Citations (Scopus)

Relationships between clinical assessments and patients' perceptions of the effects of heart failure on their quality of life

Rector, T. S., Anand, I. S. & Cohn, J. N., Mar 1 2006, In : Journal of cardiac failure. 12, 2, p. 87-92 6 p.

Research output: Contribution to journalArticle

Heart Failure
Quality of Life
Valsartan
Pathology
Dyspnea
7 Citations (Scopus)

Signs and symptoms in chronic heart failure: Relevance of clinical trial results to point of care-data from Val-HeFT

Wong, M., Staszewsky, L., Carretta, E., Barlera, S., Latini, R., Chiang, Y. T., Glazer, R. D. & Cohn, J. N., Aug 1 2006, In : European Journal of Heart Failure. 8, 5, p. 502-508 7 p.

Research output: Contribution to journalArticle

Valsartan
Point-of-Care Systems
Signs and Symptoms
Heart Failure
Clinical Trials
48 Citations (Scopus)

The Prognostic Value of Big Endothelin-1 in More Than 2,300 Patients With Heart Failure Enrolled in the Valsartan Heart Failure Trial (Val-HeFT)

Masson, S., Latini, R., Anand, I., Barlera, S., Judd, D., Salio, M., Perticone, F., Perini, G., Tognoni, G. & Cohn, J. N., Jun 1 2006, In : Journal of cardiac failure. 12, 5, p. 375-380 6 p.

Research output: Contribution to journalArticle

Valsartan
Endothelin-1
Brain Natriuretic Peptide
Heart Failure
Mortality
28 Citations (Scopus)
African Americans
ethnicity
Heart Failure
Medicine
medicine
4 Citations (Scopus)

What is the role of angiotensin-receptor blockade in cardiovascular protection?

Cohn, J. N., Nov 1 2006, In : American Heart Journal. 152, 5

Research output: Contribution to journalArticle

Angiotensin Receptors
Vascular Diseases
Cardiovascular Diseases
Renin-Angiotensin System
Angiotensin II
2005
4 Citations (Scopus)

A-HeFT: Old dog, new endothelial tricks

Cohn, J. N., Sep 23 2005, In : Texas Heart Institute Journal. 32, 3, p. 366-368 3 p.

Research output: Contribution to journalArticle

Nitric Oxide
Dogs
Heart Failure
Vascular Diseases
African Americans
206 Citations (Scopus)

Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: Results from Val-HeFT

Anand, I. S., Kuskowski, M. A., Rector, T. S., Florea, V. G., Glazer, R. D., Hester, A., Chiang, Y. T., Aknay, N., Maggioni, A. P., Opasich, C., Latini, R. & Cohn, J. N., Aug 23 2005, In : Circulation. 112, 8, p. 1121-1127 7 p.

Research output: Contribution to journalArticle

Anemia
Hemoglobins
Heart Failure
Morbidity
Mortality
108 Citations (Scopus)

Anemia in patients with heart failure: Prevalence and prognostic role in a controlled trial and in clinical practice

Maggioni, A. P., Opasich, C., Anand, I., Barlera, S., Carbonieri, E., Gonzini, L., Tavazzi, L., Latini, R. & Cohn, J., Jan 1 2005, In : Journal of Cardiac Failure. 11, 2, p. 91-98 8 p.

Research output: Contribution to journalArticle

Controlled Clinical Trials
Anemia
Valsartan
Heart Failure
Registries
56 Citations (Scopus)
Cardiovascular Agents
Congenital Heart Defects
Elasticity
Cardiovascular Diseases
Arteries
13 Citations (Scopus)

Clinical and analytical considerations in the study of health status in device trials for heart failure

Normand, S. L. T., Rector, T. S., Neaton, J., Piña, I. L., Lazar, R. M., Proestel, S. E., Fleischer, D. J., Cohn, J. N. & Spertus, J. A., Jan 1 2005, In : Journal of cardiac failure. 11, 5 SPEC. ISS., p. 396-403 8 p.

Research output: Contribution to journalArticle

Health Status
Heart Failure
Equipment and Supplies
Education
Health Resources
291 Citations (Scopus)

C-reactive protein in heart failure: Prognostic value and the effect of Valsartan

Anand, I. S., Latini, R., Florea, V. G., Kuskowski, M. A., Rector, T., Masson, S., Signorini, S., Mocarelli, P., Hester, A., Glazer, R. & Cohn, J. N., Sep 6 2005, In : Circulation. 112, 10, p. 1428-1434 7 p.

Research output: Contribution to journalArticle

Valsartan
C-Reactive Protein
Heart Failure
Angiotensin-Converting Enzyme Inhibitors
39 Citations (Scopus)

Effect of valsartan on quality of life when added to usual therapy for heart failure: Results from the Valsartan Heart Failure Trial

Majani, G., Giardini, A., Opasich, C., Glazer, R., Hester, A., Tognoni, G., Cohn, J. N. & Tavazzi, L., Jan 1 2005, In : Journal of cardiac failure. 11, 4, p. 253-259 7 p.

Research output: Contribution to journalArticle

Valsartan
Heart Failure
Quality of Life
Placebos
Therapeutics
115 Citations (Scopus)

Expanding the definition and classification of hypertension.

Giles, T. D., Berk, B. C., Black, H. R., Cohn, J. N., Kostis, J. B., Izzo, J. L. & Weber, M. A., Jan 1 2005, In : Journal of clinical hypertension (Greenwich, Conn.). 7, 9, p. 505-512 8 p.

Research output: Contribution to journalArticle

Hypertension
Cardiovascular Diseases
Prehypertension
Blood Pressure
Cardiovascular Abnormalities
82 Citations (Scopus)

Relationship between C-reactive protein and arterial stiffness in an asymptomatic population

Duprez, D., Somasundaram, P. E., Sigurdsson, G., Hoke, L., Florea, N. & Cohn, J. N., Jul 1 2005, In : Journal of Human Hypertension. 19, 7, p. 515-519 5 p.

Research output: Contribution to journalArticle

Vascular Stiffness
C-Reactive Protein
Arteries
Elasticity
Population
341 Citations (Scopus)

Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT)

Maggioni, A. P., Latini, R., Carson, P. E., Singh, S. N., Barlera, S., Glazer, R., Masson, S., Cerè, E., Tognoni, G. & Cohn, J. N., Jan 1 2005, In : American Heart Journal. 149, 3, p. 548-557 10 p.

Research output: Contribution to journalArticle

Valsartan
Atrial Fibrillation
Heart Failure
Incidence
Brain Natriuretic Peptide
2004
10 Citations (Scopus)

ACCF/AHA consensus conference report on professionalism and ethics: Cardiovascular professionalism and ethics in the modern era

Adams, R. J., Alpert, J. S., Anderson, J. L., Annex, B. H., Antman, E. M., Bellande, B., Beller, G. A., Bilheimer, D. W., Bonow, R. O., Brown, N. A., Califf, R. M., Cheitlin, M. D., Cohn, J. N., Collishaw, K. J., DeMaria, A. N., Douglas, P. S., Faxon, D. P., Feigal, D. W., Fonarow, G. C., Friedman, L. & 48 others, Frye, R. L., Fuster, V., Gardner, T. J., Garson, A., Gibbons, R. J., Goldstein, L. B., Grant, A. O., Hampson, L. A., Harrington, R. A., Hines, E. F., Hirshfeld, J. W., Jackson, M. J., Jacobs, A. K., Kavey, R. E. W., Kimball, H. R., Korn, D., Lima, J. A. C., Lindsay, B. D., Livingston, D. W., Lorell, B. H., McEntee, C. W., Merz, J. F., Messer, J. V., Nishimura, R. A., Nissen, S. E., Ofili, E., Ohman, E. M., Parmley, W. W., Pepine, C. J., Peterson, E. D., Pitt, B., Popp, R. L., Prystowsky, E. N., Rahimtoola, S. H., Ritchie, J. L., Robertson, R. M., Ryan, T. J., Shah, P. M., Shine, K. I., Smaha, L. A., Smith, S. C., Wann, L. S., Whitman, G. R., Willerson, J. T., Wolk, M. J., Zipes, D. P., Popp, R. L. & Smith, S. C., Oct 19 2004, In : Circulation. 110, 16, p. 2506-2511 6 p.

Research output: Contribution to journalArticle

Truth Disclosure
Marketing of Health Services
Human Experimentation
Professional Ethics
Codes of Ethics
35 Citations (Scopus)

Antihypertensive utility of perindopril in a large, general practice-based clinical trial.

Julius, S., Cohn, J. N., Neutel, J., Weber, M., Turlapaty, P., Shen, Y., Dong, V., Batchelor, A. & Lagast, H., Jan 1 2004, In : Journal of clinical hypertension (Greenwich, Conn.). 6, 1, p. 10-17 8 p.

Research output: Contribution to journalArticle

Perindopril
General Practice
Antihypertensive Agents
Clinical Trials
Blood Pressure
20 Citations (Scopus)

Clinical experience with perindopril in African-American hypertensive patients: A large United States community trial

Cohn, J. N., Julius, S., Neutel, J., Weber, M., Turlapaty, P., Shen, Y., Dong, V., Batchelor, A., Guo, W. & Lagast, H., Jan 1 2004, In : American Journal of Hypertension. 17, 2, p. 134-138 5 p.

Research output: Contribution to journalArticle

Perindopril
African Americans
Hypertension
Physicians
Antihypertensive Agents
3 Citations (Scopus)

Clinical experience with perindopril in elderly hypertensive patients: A subgroup analysis of a large community trial

Neutel, J. M., Weber, M. A., Julius, S., Cohn, J. N., Turlapaty, P., Shen, Y., Guo, W., Batchelor, A. & Lagast, H., Nov 9 2004, In : American Journal of Cardiovascular Drugs. 4, 5, p. 335-341 7 p.

Research output: Contribution to journalArticle

Perindopril
Blood Pressure
Hypertension
Age Groups
Physicians

Clinical research: Whose agenda is it?

Cohn, J. N., May 18 2004, In : Circulation. 109, 19, p. 2256-2262 7 p.

Research output: Contribution to journalArticle

21st Century History
Cardiovascular Diagnostic Techniques
20th Century History
Autobiography
Point-of-Care Systems
5 Citations (Scopus)

Definition, classification, and staging of the adult cardiomyopathies: A proposal for revision

Giles, T. D., Chatterjee, K., Cohn, J. N., Colucci, W. S., Feldman, A. M., Ferrans, V. J. & Roberts, R., Jan 1 2004, In : Journal of Cardiac Failure. 10, 1, p. 6-8 3 p.

Research output: Contribution to journalArticle

Cardiomyopathies
Heart Failure
79 Citations (Scopus)

Determinants of radial artery pulse wave analysis in asymptomatic individuals

Duprez, D., Kaiser, D. R., Whitwam, W., Finkelstein, S. M., Belalcazar, A., Patterson, R. P., Glasser, S. & Cohn, J. N., Aug 1 2004, In : American Journal of Hypertension. 17, 8, p. 647-653 7 p.

Research output: Contribution to journalArticle

Pulse Wave Analysis
Radial Artery
Pulse
Pressure
Vascular Stiffness
92 Citations (Scopus)

Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure: Results from Val-HeFT

Krum, H., Carson, P., Farsang, C., Maggioni, A. P., Glazer, R. D., Aknay, N., Chiang, Y. T. & Cohn, J. N., Dec 1 2004, In : European Journal of Heart Failure. 6, 7, p. 937-945 9 p.

Research output: Contribution to journalArticle

Valsartan
Angiotensin-Converting Enzyme Inhibitors
Heart Failure
Placebos
Therapeutics
271 Citations (Scopus)

Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the Endothelin A Receptor Antagonist Trial in Heart Failure (EARTH): Randomised, double-blind, placebo-controlled trial

Anand, P. I., McMurray, P. J., Cohn, P. J. N., Konstam, P. M. A., Notter, T., Quitzau, K., Ruschitzka, F. & Lüscher, P. T. F., Jul 24 2004, In : Lancet. 364, 9431, p. 347-354 8 p.

Research output: Contribution to journalArticle

Ventricular Remodeling
Heart Failure
Placebos
Endothelins
Mineralocorticoid Receptor Antagonists
28 Citations (Scopus)

Morbidity, mortality, physiologic and functional parameters in elderly and non-elderly patients in the valsartan heart failure trial (Val-HeFT)

Baruch, L., Glazer, R. D., Aknay, N., Vanhaecke, J., Thomas Heywood, J., Anand, I., Krum, H., Hester, A. & Cohn, J. N., Dec 1 2004, In : American Heart Journal. 148, 6, p. 951-957 7 p.

Research output: Contribution to journalArticle

Valsartan
Heart Failure
Morbidity
Mortality
Left Ventricular Function
1 Citation (Scopus)

No baseline for blood pressure in ordinary life: Another case of transient chronome alterations

Sarabandi, T., Cohn, J. N., Cornelissen-Guillaume, G. G., Halberg, F., Katinas, G., Holte, J., Schwartzkopff, O. & Otsuka, K., Oct 1 2004, In : Biomedicine and Pharmacotherapy. 58, SUPPL. 1, p. S107-S110

Research output: Contribution to journalArticle

Blood Pressure
Elasticity
Weight Loss
Reference Values
Heart Rate
143 Citations (Scopus)

Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure: Valsartan heart failure trial (Val-HeFT) echocardiographic data

Wong, M., Staszewsky, L., Latini, R., Barlera, S., Glazer, R., Aknay, N., Hester, A., Anand, I. & Cohn, J. N., Jun 2 2004, In : Journal of the American College of Cardiology. 43, 11, p. 2022-2027 6 p.

Research output: Contribution to journalArticle

Valsartan
Ventricular Remodeling
Heart Failure
Odds Ratio
Placebos
4 Citations (Scopus)

Task force 2: Investigator participation in clinical research

Califf, R. M., Nissen, S. E., Demaria, A. N., Ohman, E. M., Pitt, B., Willerson, J. T., Bilheimer, D. W., Cohn, J. N., Feigal, D. W., Hampson, L., Lorell, B. H., Pepine, C. J. & Popp, R. L., Oct 19 2004, In : Journal of the American College of Cardiology. 44, 8, p. 1729-1736 8 p.

Research output: Contribution to journalArticle

Conflict of Interest
Medical Ethics
Medical Societies
Advisory Committees
Research Design
287 Citations (Scopus)

The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT

Latini, R., Masson, S., Anand, I., Salio, M., Hester, A., Judd, D., Barlera, S., Maggioni, A. P., Tognoni, G. & Cohn, J. N., Feb 1 2004, In : European heart journal. 25, 4, p. 292-299 8 p.

Research output: Contribution to journalArticle

Brain Natriuretic Peptide
Neurotransmitter Agents
Heart Failure
Aldosterone
Mortality
99 Citations (Scopus)

Usefulness of B-Type Natriuretic Peptide Assay in the Assessment of Symptomatic State in Hypertrophic Cardiomyopathy

Maron, B. J., Tholakanahalli, V. N., Zenovich, A. G., Casey, S. A., Duprez, D., Aeppli, D. M. & Cohn, J. N., Mar 2 2004, In : Circulation. 109, 8, p. 984-989 6 p.

Research output: Contribution to journalArticle

Brain Natriuretic Peptide
Hypertrophic Cardiomyopathy
Heart Failure
Biomarkers
Confounding Factors (Epidemiology)
2003
255 Citations (Scopus)

Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON)

Cohn, J. N., Pfeffer, M. A., Rouleau, J., Sharpe, N., Swedberg, K., Straub, M., Wiltse, C. & Wright, T. J., Oct 1 2003, In : European Journal of Heart Failure. 5, 5, p. 659-667 9 p.

Research output: Contribution to journalArticle

moxonidine
Heart Failure
Mortality
Placebos
Imidazoline Receptors
656 Citations (Scopus)

Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT)

Anand, I. S., Fisher, L. D., Chiang, Y. T., Latini, R., Masson, S., Maggioni, A. P., Glazer, R. D., Tognoni, G. & Cohn, J. N., Mar 11 2003, In : Circulation. 107, 9, p. 1278-1283 6 p.

Research output: Contribution to journalArticle

Valsartan
Brain Natriuretic Peptide
Norepinephrine
Heart Failure
Morbidity
37 Citations (Scopus)

Effect of valsartan on hospitalization: Results from Val-HeFT

Carson, P., Tognoni, G. & Cohn, J. N., Jan 1 2003, In : Journal of cardiac failure. 9, 3, p. 164-171 8 p.

Research output: Contribution to journalArticle

Valsartan
Hospitalization
Heart Failure
Angiotensin-Converting Enzyme Inhibitors
Placebos
3 Citations (Scopus)
Ventricular Remodeling
Angiotensin Receptor Antagonists
Angiotensins
Renin-Angiotensin System
Angiotensin-Converting Enzyme Inhibitors
1 Citation (Scopus)

Nitric oxide role in heart failure: Pathophysiology and treatment. Discussion

Cohn, J. N., Loscalzo, J., Vita, J., Gibbons, G., Duncan, P., Yancy, C. & Taylor, A., Oct 1 2003, In : Journal of cardiac failure. 9, 5 SUPPL. 3, p. S205-S209

Research output: Contribution to journalArticle

6 Citations (Scopus)

Nitric oxide role in heart failure: Pathophysiology and treatment: Introduction

Cohn, J. N., Loscalzo, J. & Franciosa, J. A., Oct 1 2003, In : Journal of Cardiac Failure. 9, 5 SUPPL. 3

Research output: Contribution to journalArticle

Nitric Oxide
Heart Failure
487 Citations (Scopus)

Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: An observational study

Anker, S. D., Negassa, A., Coats, A. J. S., Afzal, R., Poole-Wilson, P. A., Cohn, J. N. & Yusuf, S., Mar 29 2003, In : Lancet. 361, 9363, p. 1077-1083 7 p.

Research output: Contribution to journalArticle

Angiotensin-Converting Enzyme Inhibitors
Observational Studies
Weight Loss
Heart Failure
Therapeutics